A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Clinical trial NCT06232083 · RECRUITING

Trial details

NCT number: NCT06232083
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Esophageal Cancer Cervical Cancer

Start date: 2025-09-01
Primary completion: 2027-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.